Ascendiant Capital Markets Lowers 60 Degrees Pharmaceuticals (NASDAQ:SXTP) Price Target to $3.70
60 Degrees Pharmaceuticals (NASDAQ:SXTP – Get Free Report) had its price target decreased by equities researchers at Ascendiant Capital Markets from $4.20 to $3.70 in a report issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Ascendiant Capital Markets’ price objective would suggest a potential upside of 148.32% from the […]
22 May 08:21 · The Cerbat Gem